Therapy Areas: Diabetes
Foventa makes key CMO and CFO appointments
3 September 2026 - Foventa Therapeutics, a biotechnology company focused on novel therapies for retinal vascular diseases, announced on Wednesday that it has further strengthened its management team w...
Ascletis Pharma Inc doses first participant in global Phase III clinical programme of ASC30
31 August 2026 - Ascletis Pharma Inc. (Ascletis) (HKEX: 1672), a fully integrated biotechnology company, announced on Sunday that it has dosed its first participant in a global Phase III clinical prog...
Daiichi Sankyo data highlight real-world impact of bempedoic acid on cardiovascular risk
28 August 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) said on Friday that new analyses from the multinational MILOS study demonstrate the real-world impact of bempedoic acid, u...
Nippon Kinzoku begins mass production of ultra-thin stainless steel for insulin needles
26 August 2026 - Japanese stainless steel products manufacturer Nippon Kinzoku Co Ltd (TOKYO:5491) announced on Wednesday that it has begun mass production of ultra-thin, narrow-width stainless steel ...
Hanmi Pharm enters exclusive licensing deal with Genentech for obesity therapy HM17321
24 August 2026 - South Korean pharmaceutical company Hanmi Pharm Co Ltd announced on Monday that it has entered into an exclusive licensing agreement with Genentech, a member of the Roche Group (SIX: ...
Annexin Pharmaceuticals receives proposed INN vanexin for ANXV
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed Internatio...